chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe chills; aches; general malaise, low grade fever lasting 2-3 hours.  Acetaminophen and ibuprofen
Heart, Chest Pain, very high blood pressure during entire flight starting directly after take-off.  Crew was informed and assisted after landing in to Airport Emergency Clinic. Upper Blood pressure was above 180, ECG check performed and recommended to not fly further (our final destination). Pain medication treatment ordered. Never fully recovered, had elevated blood pressure since. Since October 2022 during stay at Lake Tahoe high altitude left leg pain and swelling on daily basis, upper blood pressure around 140. November 2022 chest pain, pressure, heart problems resurface, blood pressure variably from 135 to above 180. Cannot travel by plane anymore (would be due to fly early December 2022, which I cannot as my heart problems are too dangerous to fly), my life is reduced to sitting around and not being active anymore. Suspected myocarditis.
Patient began to "not feel well" starting around 10 PM the evening she was vaccinated (Friday). Saturday morning she still was not feeling well and thought she might have fever. She also had a headache. She slept "all day" and is normally very active. Her arm also hurt and the injection site of the BEXSERO was swollen, red, painful, and hard. She took her temperature Saturday afternoon and it was 100.5. She began feeling nauseated sometime on Saturday as well, and vomited around 8:00 PM. Sunday she felt about the same, still had nausea, fever, headache, and injection site pain. She vomited again around 5:30 PM. Monday she has not vomited, but still does not feel well.
Pain at injection site, woke up next morning with double vision. With both eyes open, dizziness, loss of depth perception
Damage to the 7th Cranial Nerve / hemifacial spasms; elevated blood pressure and pains and aches all over my body.
This 18 year old female who was otherwise always healthy and active received a 3rd Gardasil injection in May 2008. The first two were administered in late 2007. This female was a top ranked soccer player and was getting ready to attend a Division1 program on a full scholarship. She was training for college soccer around July 2008 when she began to feel tightness in her calves upon running. The pain would cease once she stopped running and she continued to push through the tightness until she began to notice the tightness had spread to the anterior compartments of both lower legs. She described that pain as a burning pain. The pain began to increase with other exertions besides running i.e. jumping, squatting, flexing her feet and climbing stairs. She then was unable to continue playing soccer due to the pain. Of interest is that in addition to the extreme exertional muscle pain, she ceased menstruating for approximately 8 months and her menses only resumed after a course of LoEstrin FE. After a gynecological workup, the patient was found to have extremely low levels of estrogen. Her C4A levels have also been repeatedly extremely high and she tested positive for XMRV and mycoplasma pneumoniae. About a year and a half after the initial symptom of calf tightness, she began to notice a burning in her forearms and upper arms while performing exertions with her arms. These exertions were as simple as cutting a piece of paper, carrying a gallon of milk or blow drying her hair. Around this time, she also noticed the same symptoms she was experiencing in her lower legs, in her quadriceps as well. She has been examined by numerous medical specialists (orthopedic, neurology, vascular, rheumatology, Infectious Disease, neuromuscular, endocrinology, gynecology) all with relatively normal findings. She was diagnosed and attempted to be treated for the following: exertional compartment syndrome (three bilateral fascietomies), fibromyalgia, metabolic muscle disease, Lyme Disease and tick borne illness.  She has taken numerous vitamins and supplements, trials of Lyrica, Neurontin, Prednisone, antibiotics and parasite medications to no avail.  This female patient, in the matter of three and a half years, went from being a top level athlete who exercised every day, to experiencing extreme muscle pain upon any exertion and preventing her from participating in any physical activity due to her marked pain.
Left deltoid area indurated 5x4 cm2 and warm in site of injection, also dizziness, nausea, and low grade temperature
Extreme shaking 3 hours after the vaccine.  Within one month patient was having difficulty walking, feeling very weak.  Was admitted into the hospital end of July/early August. Has been there for over a month.  Paralysis.  Can barely feed himself, Can not stand, walk or turn over in the bed.
This case was reported by a consumer and described the occurrence of a nonspecific reaction in a female subject of unspecified age who was vaccinated with HAVRIX. A physician or other health care professional has not verified this report. On 1 May 2006 the subject received unspecified dose of HAVRIX (unknown). At an unspecified time after vaccination with HAVRIX, the subject experienced a terrible nonspecific reaction. At the time of reporting the outcome of the event was unspecified.
Initial non-serious report received from a non-health professional on 19-October 2007.  A male patient (age unknown) had received FLUZONE (lot number 02464AA; route/site of administration not indicated) on an unspecified date in 2007.  He developed cellulitis (location and onset date not reported) and received treatment with KEFLEX.  The FLUZONE vaccination was administered with a 23 gauge, one inch needle.  Patient outcome was not reported.  No additional information has been provided at the time of the report.  The reporter of this case is the same as for case 2007-03529, which involves cellulitis, swollen arm, itching and injection site redness following receipt of FLUZONE, lot number U2466AA.
Developed vomiting with liquid & solids the day after receiving vaccine. Continued for 7 days. No fever, diarrhea.
Red wheal 24 hours after vaccine was given. OTC Benadryl 50mg Q12 hours for 48 hours. Benadryl and Decadron IM at doctors office.
covid vaccine given at 1309 approv 3-5 minutes later felt cold, lightheadedness, tingling, nausea.  No shortness of breath VSS.  No rash, swelling.  Feels cold to touch, pale.    placed in supine position with blanket.  Not as lightheaded Nausea improving s/p ondansetron 4 mg ODT @ 14:00.
mom states pt had an adverse react to Previous shots; states pt had an episode of crying w/ a high pitch lasting approx 3 hrs beginning 3-4 hrs p/shots given;
Information has been received from a licensed practical nurse concerning a 5 months old patient of unknown gender who on 22-OCT-2014 was vaccinated with ROTATEQ (lot # J014868, expiration date 13-OCT-2015), oral (dose not reported). The vaccine was reported to have temperature excursions from 10-SEP-2014 to 12-SEP-2014. No adverse reports. This is one of several reports from the same source. Additional information is not expected because all follow ups requested to complete the case were received.
This spontaneous case, initially received on 19-Dec-2016, was reported by a health professional and concerns a(n) 62-year-old male patient. Weight: not provided: Height: not provided. Concomitant medication: refer to appropriate report section. Administration of company suspect drug(s): The patient received AFLURIA from 23-NOV-2016 to 23-NOV-2016. Dose regimen: 0.5 ml, Route of administration: Intramuscular. Batch number: WT57008. No additional suspect drugs. Between 20-Nov-2016 and 21-Nov-2016, the AFLURIA vaccine underwent first excursion. The vaccine was stored at 35.76 degree F for about 2 hours. The pharmacist stated that the thermometer was fluctuating in the previous location in the refrigerator and was moved to the top shelf. On 21-Nov-2016, the patient received the vaccine that underwent temperature excursion. Special circumstances: Incorrect product storage without adverse event. Drug administration error without adverse event.
I have become type 2 diabetic since vaccinated; covid-19 infection; This spontaneous case was reported by a patient and describes the occurrence of TYPE 2 DIABETES MELLITUS (I have become type 2 diabetic since vaccinated) and COVID-19 (covid-19 infection) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Concurrent medical conditions included Bipolar affective disorder and Fruit allergy (Apples pistachios).   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Sep-2021, the patient experienced TYPE 2 DIABETES MELLITUS (I have become type 2 diabetic since vaccinated) (seriousness criteria hospitalization and medically significant) and COVID-19 (covid-19 infection) (seriousness criterion hospitalization). The patient was hospitalized for 5 days due to COVID-19 and TYPE 2 DIABETES MELLITUS. The patient was treated with INSULIN at an unspecified dose and frequency. At the time of the report, TYPE 2 DIABETES MELLITUS (I have become type 2 diabetic since vaccinated) and COVID-19 (covid-19 infection) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Sep-2021, SARS-CoV-2 test: Positive. On 17-Nov-2022, SARS-CoV-2 test: (Negative) Nasal Swab.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant medication was reported. Co- suspect was reported as Phizer sucrose Bivalent, dose 3 (left arm)  Company comment: This spontaneous case concerns a 37-years-old male patient, with no relevant reported medical history, who experienced the unexpected serious (hospitalization and medically significant) event of  Type 2 diabetes mellitus and unexpected serious (medically significant) event of COVID-19 with Positive SARS-CoV-2 test that occurred on unspecified days after receiving second dose of mRNA-1273 vaccine.The events outcome was reported as not recovered.The patient was treated with INSULIN  No information on risk factors, detailed clinical course, investigations, concomitant medication, and treatment received are available for review. The causality of the event COVID-19 was assessed as not applicable, due to lack of biologic plausibility. The event might be explained by current pandemic outbreak. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Mild, Systemic: Nausea-Mild, Additional Details: Fainted, came to immediately, sat for 10 minutes, drank water, then felt fine, paramedics cleared her
Administration error: 26 doses administered to adult patients from pediatric vials instead of bivalent vaccine; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (Administration error: 26 doses administered to adult patients from pediatric vials instead of bivalent vaccine) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Administration error: 26 doses administered to adult patients from pediatric vials instead of bivalent vaccine) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Administration error: 26 doses administered to adult patients from pediatric vials instead of bivalent vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Administration error: 26 doses administered to adult patients from pediatric vials instead of bivalent vaccine).    No concomitant medication was reported. The HCP reported that on 08-Oct-2022, 09-Oct-2022 and 10-Oct-2022, 26 doses to adult patients from pediatric vials of Moderna COVID-19 Vaccine instead of bivalent booster were administered. No treatment medication was reported.
Pt recv vax on 5/22/98; on same day pt exp fever, chills, aches, fatigue, diarrhea, dec appetite, inc liver function; on 6/3/98 pt exp jaundice, 10 lb weight loss; on 6/22/98 pt imp
7 days after infection, vaccine shot area is red, warm to the touch, sore and a lump is present under the skin. Each day red area has grown larger.
Retina detachment in left eye 90% macular and retinal tear (hole) in right eye. Required 3 eye surgeries (detachment repair and cataract surgeries in both eyes. Plus 2 laser procedures to repair retina tears in right eye. All conducted from Mar 2021 thru Dec 2021.
After vaccination, pt was sitting with father and in about 5 mins she fainted, eyes open but no consciousness. Came to but was very hot and sweaty.
Diffuse hives to body and face which started tonight around 8pm . Pt noted a headache yesterday which she expected. No difficulty breathing.
more than 48 hrs of inconsolable cry & high fever; almost 2 wks of subdued activity; not cooing; nl @ f/u;
Patient reported to pharmacy on 9/5/20, 2 days post-vaccination.  Presented with symptoms in left upper arm, but lower than where the vaccination was administered.  He experienced warmth, redness, and a rough edge in one area where affected skin met normal skin.  He reported symptoms started about 8 hours post-vaccination. Follow-up on 9/10/20, patient reported no worsening of symptoms after visiting the pharmacy, and symptoms have now resolved.
Low grade temp and ache on 5/4/03. Rash started on 5/4/03 over entire body, swollen-painful right knee.
Patient is exp cold chills stated she has been sanding on top of the heater since she got home. The other symptoms are severe numbness on both sides of head and neck. She having weakness in the stomach.
Vaccination failure; Tested positive for the A strain of the flu; Feeling ill; Positive for A strain of the flu; Persistent cough; This is a spontaneous case initially received from other non-health professional (consumer) on 05-Feb-2019, concerning a 48-year-old, adult male patient.  The patient had no medical history. The patient had not received any concomitant medications.  On an unspecified date in 2018 (reported as sometime in September or October 2018), the patient was administered Flucelvax QIVc (influenza vaccine, subunit influenza virus vaccine polyvalent, cell-culture-derived, dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch number and expiry date: not reported) for active immunization against influenza.  On 05-Feb-2019, 4 or 5 months after vaccination, the patient started feeling ill and experienced persistent cough. The same day, patient went to the doctor. The patient was tested positive for the A strain of the flu (influenza A virus infection) (explicitly coded as vaccination failure). The patient was treated with Tamiflu (oseltamivir phosphate) for the event.  The outcome of the events ill feeling, and influenza was recovering, and the outcome of the event persistent cough was not recovered.  The reporter assessed the case as non-serious.  Non-significant follow-up received from the reporter on 20-Mar-2019: Added reference number (med info number: SEQ19-00828) was added in the additional information. It was reported that, 3 attempts were made to reach the patient on 20-Feb-2019, 27-Feb-2019 and 01-Mar-2019 but was unable to obtain the requested information. No new information was received. Hence, no changes were made in the narrative.; Reporter's Comments: A 48-year-old male patient experienced malaise and cough and was diagnosed to have influenza, 4 to 5 months after Flucelvax QIV vaccination (coded to influenza and vaccination failure). Considering the fact that vaccine needs minimum 2-3 weeks to provide immune protection against influenza, vaccination failure and causal role of suspect vaccine for the event influenza cannot be ruled out and were assessed as related to suspect vaccine. Further assessment will be done upon receipt of new information. The company assessed the case as serious (medically significant).
Acute cerebrovascular accident - MRI brain showed findings suggestive of acute or early subacute infarct involving posterior medial left thalamus with posterior inferior focal extension. Stroke Neurology consulted and assisted with stroke work up. CTAngio Head and Neck with findings of acute thrombus in distal R vertebral artery and patient was started on Heparin drip per Stroke Neurology recommendations. Then started on po Warfarin with Lovenox bridge until INR therapeutic as pt pulling at Heparin gtt with confusion. Patient has been medically stable and placement for STR has been secured but likely will transition to LTC with ongoing dementia type behaviors. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.
This case was reported by a pharmacist  and described the occurrence of injection site soreness in an adult  subject of unspecified gender who was vaccinated with influenza virus vaccine for prophylaxis. On an unspecified date on or after 10/18/05 and on or before 10/28/05 the subject received a dose of Fluarix. The site of injection of the Fluarix was not provided. On an unspecified date in 10/05, less than one month after vaccination with Fluarix, the subject experienced injection site soreness. The injection site soreness resolved on an unspecified date on or before 11/28/05.
lethargy; stomach is the big problem; don't feel like eating anything; Stomach just hurts like when you want to throw up but can't throw up; it's just dry heaves; achiness; headaches all the time but the headaches have increased a little more than used to before; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (lethargy), ABDOMINAL DISCOMFORT (stomach is the big problem; don't feel like eating anything), ABDOMINAL PAIN UPPER (Stomach just hurts like when you want to throw up but can't throw up; it's just dry heaves), MYALGIA (achiness) and HEADACHE (headaches all the time but the headaches have increased a little more than used to before) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026B21A and 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ATENOLOL and PAROXETINE for an unknown indication.   On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form(s). On 04-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 06-Apr-2021, the patient experienced LETHARGY (lethargy), ABDOMINAL DISCOMFORT (stomach is the big problem; don't feel like eating anything), ABDOMINAL PAIN UPPER (Stomach just hurts like when you want to throw up but can't throw up; it's just dry heaves), MYALGIA (achiness), HEADACHE (headaches all the time but the headaches have increased a little more than used to before) and NAUSEA (Nausea). The patient was treated with ONDANSETRON for Nausea, at a dose of 4 mg. At the time of the report, LETHARGY (lethargy), ABDOMINAL DISCOMFORT (stomach is the big problem; don't feel like eating anything), ABDOMINAL PAIN UPPER (Stomach just hurts like when you want to throw up but can't throw up; it's just dry heaves), MYALGIA (achiness), HEADACHE (headaches all the time but the headaches have increased a little more than used to before) and NAUSEA (Nausea) outcome was unknown. Not Provided          patient also takes vitamins but she said she hasn't taken them in awhile. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine)  was Not applicable.
Menstruation began approximately one week early, and menstrual cramps are stronger/more painful than usual.
One hour after the shot I became very light headed. I had a difficult time walking. My heart felt like it was racing. My left arm where the shot was given is sore 22 hours later
Severe vertigo, beginning at 6:00 AM on awakening.  Lasting severe for 2 days. Becoming less severe over the course of one week. Still experience slight dizziness.
tongue started to swell, heart was pounding,  itchy throat, itchy lips, high blood pressure, hard to swallow water
on day 1, arm was sore and patient felt tired. on day 2, patient felt achy all over. these symptoms resolved by the morning of day 3, when patient woke up about 0800 to discover she had cold sore type blisters in the inside of her mouth on her cheeks and a red rash on the roof of her mouth. Symptoms have gradually worsened over the day. Patient has not been in touch with provider at this time.
COVID-19 TEST POSITIVE; This spontaneous report received from a patient concerned a 51 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: sleep apnea, overweight, nicotine user, and allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A221A expiry: UNKNOWN) dose was not reported, administered on 21-APR-2021 15:45 for covid-19 prophylaxis. No concomitant medications were reported. On 04-OCT-2022, Laboratory data included: COVID-19 virus test Negative (No covid effects). On 05-OCT-2022, Laboratory data included: COVID-19 virus test Negative (No covid effects). On 06-OCT-2022, Laboratory data included: COVID-19 virus test Negative (No covid effects). On 07-OCT-2022, Laboratory data included: COVID-19 virus test Positive (at home). On an unspecified date, the patient experienced covid-19 test positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from covid-19 test positive. This report was non-serious. This report was associated with a product quality complaint: 90000255691.
Morning after vaccination, Tueday, she had a sore and red arm which she expected.  The next day, Wednesday,  she woke up with rash on arm at site of injection and ached all over and had chills.  By Thursday, the next day, she felt better and said that she had a couple of spots around the site of injection and by Friday and Saturday they were gone but she still felt itchy at the site.  She came to the pharmacy today, Sunday, 6 days post vaccination and the had a clear rash about the size of a slice of bread down her arm. She states that is  itchy but no issues with range of motion or soreness at the site of injection.  She states she has not tried any ice or topical steroids otc.  I told her to go home and apply an ice pack and let me know how she is doing after this.
Information has been received from a physician, concerning a female patient (born in 1989), who on 18-JUL-2007 was vaccinated with a dose of Gardasil (lot # not reported).  On 19-JUL-2007, she went swimming, and "developed bumps on her body and a rash," and also a fever (date of onset not specified).  Treatment for the rash involved unspecified steroids, and the rash resolved; however, the rash returned after the steroids were stopped.  The steroid treatment was restarted.  At the time of this report, the outcome of the fever was unknown, and the outcome of rash was not recovered.  Additional information has been requested.